Documentation
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36
Unravelling the long-term and indirect health impact of the COVID-19 crisis in Belgium
Last updated: 2022-10-15 12:19